References

1. 1.
   PATEL S G，KARLITZ J J，YEN T，et al.The rising tide of early-onset colorectal cancer： A comprehensive review of epidemiology，clinical features，biology，risk factors，prevention，and early detection［J］.Lancet Gastroenterol Hepatol，2022，7（3）：262-274.
2. 2.
   LI R，LIU X F，HUANG X D，et al.Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis［J］.Gut，2024，73（3）：470-484.
3. 3.
   BERTOCCHI A，CARLONI S，RAVENDA P S，et al.Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver［J］.Cancer Cell，2021，39（5）：708-724.e11.
4. 4.
   HUANG Y W，ZHAO M N，YIN J C，et al.Pulmonary metastasis in newly diagnosed colon-rectal cancer： A population-based nomogram study［J］.Int J Colorectal Dis，2019，34（5）：867-878.
5. 5.
   CAI Y M，ZHANG X Q，ZHAO G L，et al.Mechanism of small molecules of traditional Chinese medicine targeting tumor-associated macrophages in gastrointestinal tumors：A review ［J］.Chin J Exp Tradit Med Form，2024，30（21）：271-278.
6. 6.
   HAO X P，ZHENG Z Y，LIU H Y，et al.Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing［J］.Redox Biol，2022，56：102463.
7. 7.
   GUO M Z，YANG X Q，YANG Y Y，et al.Treatment of colorectal cancer on account of Jueyin［J］.J Pract Tradit Chin Intern Med，2020，34（11）：10-13.
8. 8.
   ZHAO H F.The effect and mechanism of Wumei pill in colorectal cancer based PD-L1/PD-1 pathway［D］.Tianjin：Tianjin Univ Tradit Chin Med，2023.
9. 9.
   DOU C W，LIU Z K，TU K S，et al.P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts［J］.Gastroenterology，2018，154（8）：2209-2221.
10. 10.
    CHEN F M，LI T L，ZHANG H J，et al.Acid-ionizable iron nanoadjuvant augments STING activation for personalized vaccination immunotherapy of cancer［J］.Adv Mater，2023，35（10）：e2209910.
11. 11.
    WANG P，LI J C，REN M L，et al.Effects of Wumei pill on gene microenvironment expression profile and immune-related gene expression in orthotopic tumor of breast cancer mice［J］.China J Tradit Chin Med Pharm，2024，39（2）：913-920.
12. 12.
    LI Q，MA Z，LIU Y H，et al.Low doses of paclitaxel enhance liver metastasis of breast cancer cells in the mouse model［J］.FEBS J，2016，283（15）：2836-2852.
13. 13.
    Shanghai Anti-Cancer Association Colorectal Cancer Committee.Shanghai plan for early screening，diagnosis and treatment of colorectal cancer（2023 edition）［J］.Chin J Cancer，2024，34（1）：13-66.
14. 14.
    ZHU D X，REN L，XU J M.Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases（2023 edition）［J］.Chin J Gen Surg，2023，32（1）：1-29.
15. 15.
    TRAN E，ROBBINS P F，LU Y C，et al.T-cell transfer therapy targeting mutant KRAS in cancer［J］.N Engl J Med，2016，375（23）：2255-2262.
16. 16.
    JIANG Z C，ZHANG W，ZHOU A P.Research progress on triplet chemotherapy for advanced colorectal cancer［J］.Chin J Clin Oncol，2021，48（4）：201-205.
17. 17.
    WEI X M，LI L，CHENG H B.Discuss on the pathogenesis of colorectal precancerous from the perspective of traditional Chinese medicine［J］.J Nanjing Univ Chin Med，2021，37（3）：348-351.
18. 18.
    LI J，WANG Z W，DENG J，et al.Discussion on feasibility of Wumei pill in the treatment of colorectal cancer［J］.World Chin Med，2023，18（8）：1178-1182.
19. 19.
    CHEN H B，LIN C Z.Wumei pill in treatment of diseases of large intestine： A review［J］.Chin J Exp Tradit Med Form，2023，29（1）：250-257.
20. 20.
    ZHANG R，LI S J，CHEN Z Y，et al.Mechanism exploration of modified Wumei pill on colon cancer inhibition via Wnt pathways［J］.World Chin Med，2018，13（8）：1972-1975.
21. 21.
    CHRISTOFIDES A，STRAUSS L，YEO A，et al.The complex role of tumor-infiltrating macrophages［J］.Nat Immunol，2022，23（8）：1148-1156.
22. 22.
    MANTOVANI A，ALLAVENA P，MARCHESI F，et al.Macrophages as tools and targets in cancer therapy［J］.Nat Rev Drug Discov，2022，21（11）：799-820.
23. 23.
    CHEN S Z，SAEED A F U H，LIU Q，et al.Macrophages in immunoregulation and therapeutics［J］.Sig Transduct Target Ther，2023，8（1）：207.
24. 24.
    LOCATI M，CURTALE G，MANTOVANI A. Diversity，mechanisms， and significance of macrophage plasticity［J］.Annu Rev Pathol，2020，15（1）：123-147.
25. 25.
    GUO M X，LIN Y X，CAI M Y，et al.Traditional Chinese medicine regulates tumor-associated macrophages in colorectal cancer：A review［J］.Chin J Exp Tradit Med Form，2024，30（22）：279-288.
26. 26.
    MANTOVANI A，MARCHESI F， MALESCI A，et al.Tumour-associated macrophages as treatment targets in oncology［J］.Nat Rev Clin Oncol，2017，14（7）：399-416.
27. 27.
    LI H，XIAO Y，LI Q，et al.The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1［J］.Cancer cell，2022，40（1）：36-52.
28. 28.
    KUMAR S.Cellular and molecular pathways of renal repair after acute kidney injury［J］.Kidney Int，2018，93（1）：27-40.
29. 29.
    WYNN T A，CHAWLA A，POLLARD J W.Macrophage biology in development，homeostasis and disease［J］.Nature，2013，496（7446）：445-455.
30. 30.
    QIAO Y Y，FU E Q.Advances in the study of tumor-associated macrophages in lung cancer ［J］.Chin J Lung Cancer，2022，25（1）：34-39.
31. 31.
    GUNASSEKARAN G R，POONGKAVITHAI VADEVOO S M，BAEK M C，et al.M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages［J］.Biomaterials，2021，278：121137.